Synthetic Peptide Synthesis — ʻElima kuhi hewa e pili ana i nā ala a me nā mea i pau

Pane wikiwiki

ʻO ka synthetic peptide synthesis kahi ala i kahi mea noiʻi i wehewehe ʻia, ʻaʻole wale he lāhui e hui pū i nā waikawa amino. ʻO ka nīnau kūpono ʻo ia ke ala e hiki ai ke del…

Synthetic Peptide Synthesis — ʻElima kuhi hewa e pili ana i nā ala a me nā mea i pau

Kuhihewa kekahi: ʻO ka lōʻihi o ke kaʻina wale nō ke koho i ke ala synthesis

ʻO ka synthetic peptide synthesis kahi ala i kahi mea noiʻi i wehewehe ʻia, ʻaʻole wale he lāhui e hui pū i nā waikawa amino. ʻO ka nīnau kūpono ʻo ia ke ala e hiki ai ke hāʻawi i ke ʻano molekala i makemake ʻia, nui, a me nā hōʻike no ka hoʻokolohua i manaʻo ʻia. He mea nui ka lōʻihi o ke kaʻina, akā ʻaʻole ia e pani i ka ʻike e pili ana i nā hoʻololi, nā hiʻohiʻona kaʻina paʻakikī, ka hoomaemae ana, a i ʻole ka hoʻohana hope ʻana.

Ke aʻo kuhiakau: Pono ke keʻena hana i kahi peptide koena 24 me kahi pūʻulu acetyl N-terminal i kuhikuhi ʻia, he waika C-terminal manuahi, a me kahi kūlana cysteine ​​i wehewehe ʻia. ʻO kāna kumu mua he hoʻohālikelike analytical, me ka piʻi ʻana o ka nui ma hope aku. ʻAʻohe synthesis, hōʻike, a i ʻole ka hopena hoʻomaʻemaʻe i manaʻo ʻia.

ʻO ka manaʻo kuhihewa ʻo kēlā me kēia peptide o kēia lōʻihi e hoʻohana i ke ala like. He kūlana ka hopena i hoʻoponopono ʻia: He moho hoʻomaka kūpono paha ka peptide synthesis paʻa paʻa, akā, pono e loiloi ʻia ka pahuhopu piha a me ka hana i lalo. ʻAʻole hiki ke ʻike ʻia ke ʻano hui a me ka hoʻokaʻawale ʻana mai nā huahana pili mai ke koena helu wale nō.

Alanui ʻO ke kumu kūpono e noʻonoʻo ai Pono nā hōʻike ma mua o ke koho ʻana
ʻO ka peptide synthesis paʻa ʻO ka hui kemika stepwise me nā hoʻololi i wehewehe ʻia a me ke kemika terminal Huipuia kiko'ī, deprotection, kaawale, and analytical feasibility
Solution-phase or chemical hybrid route Suitable fragments or intermediates may support the required process and scale Intermediate quality, joining chemistry, hoʻihoʻi hou, and final-product control
Recombinant expression and release A suitable biological construct may provide the target or a precursor Hōʻike, hoʻihoʻi hou, māwae, exact termini, hoʻololi, and final characterization
Chemical ligation of segments Compatible segments may make a difficult target more accessible Junction chemistry, segment preparation, joining outcome, a me ka hana iho

ʻO ka published tirzepatide manufacturing study documents a hybrid chemical route for its particular target and scale. It illustrates route integration, not a universal preference for hybrid manufacture or a result for this 24-residue teaching target.

No ka papahana aʻo, compare candidate routes using the same final molecular specification. A i ʻole, a route that produces an unmodified precursor may appear easier only because it has not yet completed the requested target.

Synthetic Peptide Synthesis — ʻElima kuhi hewa e pili ana i nā ala a me nā mea i pau

E kau i kēlā me kēia ala i ka laina hoʻopau like

Draw the complete chain of material states for each proposal. A chemical route might pass through a protected chain and a crude released peptide before final isolation. A recombinant route might pass through a fusion and a released precursor before any required terminal modification. A ligation route requires suitable segments before it can produce the joined chain. Compare the accepted final target after all required transformations.

Hypothetical sequence-scar example. The required product contains exactly 24 residues and the specified N-terminal acetyl group. Suppose a proposed release design instead leaves Gly–Ser before that sequence. Its product has 26 koena. ʻO ka wehewehe ʻana i kēlā mau koena ʻelua ma ke ʻano he mea hoʻopili pōʻino ʻaʻole ia e hoʻohālikelike i ka mole me ka pahuhopu i ʻae ʻia., a ʻo ka acetylating i kāna N-terminus hou ʻaʻole ia e kau i ka acetylation ma ke koena mua.

He pilikia kiko'ī kēia ma mua o ka ho'ā'o 'ana. Hiki i ke keʻena hana ke hoʻoholo e aʻo i ka mana 26-koena, akā, pono ia i ka hoʻololi i ka pahuhopu a me ka wehewehe kūpono. ʻAʻole hiki ke hōʻoia ʻia kahi pane hoʻāʻo maikaʻi i ka wā i hāʻawi ʻia ke kauoha kumu 24-koena..

Aia kekahi ʻanuʻu hoʻoponopono i manaʻo ʻia ma ke ala. Inā pono ka wehe ʻana i kahi ʻōpala a i ʻole ke kau ʻana i kahi pūʻulu terminal, komo i kona hiki, kaawale a me ka hooiaio ana. Mai hoʻohālikelike i kahi mea kemika i hoʻopau piha ʻia me kahi recombinant precursor i hoʻopau ʻole ʻia a helu i ka hana i haʻalele ʻia ma ke ʻano he ala kūpono..

Kuhihewa ʻelua: ʻO ka hoʻopau ʻana i ka hui ʻana ʻo ia ka mākaukau o ka peptide e hoʻohana

ʻO ka manaʻo kuhi hewa ʻo ia ka papahana mea hana i hoʻopau ʻia a i ʻole ke kaʻina hoʻohui kūleʻa e like me ka huahana hope loa. ʻO ka hui ʻana hoʻokahi pae. Ma muli o ke ala, māwae, deprotection, kaawale, ka hoomaemae ana, hana ʻana a maloʻo paha, a e pono ana paha ke kālailai.

Synthetic Peptide Synthesis — ʻElima kuhi hewa e pili ana i nā ala a me nā mea i pau

ʻEpekema Peptide Hiki ke ala mai nā huahana pili mai nā hopena piha ʻole a i ʻole nā ​​loli e pili ana i ke kaʻina hana. Pono e noiʻi ʻia ko lākou ʻike a me ko lākou koʻikoʻi me nā ʻano kūpono. Mai noʻonoʻo ʻo kēlā me kēia hiʻohiʻona chromatographic ʻē aʻe he peptide holoi ʻia a i ʻole ʻo kēlā me kēia kiʻekiʻe koʻikoʻi ka pahuhopu i makemake ʻia..

ʻO ka hopena i hoʻoponopono ʻia ʻo ia ka wehewehe ʻana i ka hoʻopau ʻana ma ke kiʻekiʻe o ka hoʻopuka hope loa. No ka pahuhopu hypothetical, ka acetylation i noi ʻia, ʻano hoʻopau, mokuʻāina cysteine, pili pili i ka haumia, a ʻo ka nui hiki ke hoʻohana ʻia nā mea a pau he ʻāpana o ia wehewehe.

ʻO ka hoʻohālikelike media SPE o Biotage pili i nā kūlana hoʻomaʻemaʻe i hoʻāʻo ʻia. ʻO kāna mau hopena e hoʻoikaika i ka nānā ʻana i ka pili ʻana o ka media; ʻAʻole lākou e hoʻokumu i ka maikaʻi a i ʻole ka hoʻihoʻi ʻana o kēia peptide aʻo.

Loaʻa nā hōʻike kūpono i nā hopena waena a me nā hopena hope loa, loiloi ʻike pono, ʻano pōʻaiapili, a me kahi kumu nui e kākoʻo ana i ka hoʻokolohua i hoʻolālā ʻia. ʻO kahi moʻolelo i pau ka ʻaha hui e noho mau i kahi moʻolelo hui; ʻaʻole pono e hoʻopaʻa inoa ʻia ma ke ʻano he ʻae hope loa.

Kuhihewa ʻekolu: wehe 'ia ka hua'ōlelo recombinant i ka palena a me ka ho'ololi 'ana

ʻO ka manaʻo kuhihewa ʻo ia ka hopena o ka ʻōlelo ikaika e hoʻoponopono i ka pilikia like me ka hāʻawi ʻana i ka peptide i noi ʻia. Hiki i ka ʻōlelo ke hana i kahi hui, mua, a i ʻole ka hui ʻana e pono ai ka hoʻihoʻi ʻana a me ka hana ʻana. ʻAʻole hiki ke loaʻa ka peptide pōkole i makemake ʻia i kona ʻano hope loa.

Synthetic Peptide Synthesis — ʻElima kuhi hewa e pili ana i nā ala a me nā mea i pau

Hoʻololi pololei o ka Cysteine ​​​​i loaʻa nā peptide a i ʻole nā ​​​​proteina e hoʻohana ana i nā paʻakai Alkylthiophenium ʻO Malakhov a me nā hoahana ʻo SUMO-fusion study hōʻike i kahi ʻōlelo-a-hoʻokuʻu Hoolako Imi Peptide ʻōnaehana. He mea nui kona palena substrate. E loiloi i ka hana maoli a me ka huahana kaʻawale ma mua o ka hoʻololi ʻana i kahi hopena fusion-expression maikaʻi i kēlā me kēia pahuhopu..

No ka pahuhopu acetylated hypothetical, e nīnau pehea e hoʻokō ʻia ai a hōʻoia ʻia ka hui hope N-terminal. Mai noʻonoʻo e hāʻawi ʻokoʻa i kahi ala recombinant i kēlā me kēia hoʻololi kemika a i ʻole ka waiho ʻana o ka hoʻoponopono ʻana i ka palena kūpono.. ʻO ka mokuʻāina ʻo cysteine ​​kekahi mea ʻano huahana hope loa me ka nānā ʻole i ke ʻano o ke kaulahao.

ʻO ka hopena i hoʻoponopono ʻia e loiloi i ka ʻōlelo, hoʻokuʻu, ka hoomaemae ana, a me nā hoʻololi hou aʻe ma ke ʻano he ala pili. Alakaʻi Hoʻoheheʻe Peptide Pono ka hōʻike ʻana o ka ʻōlelo fusion-protein kiʻekiʻe, akā, ʻaʻole ia e like me ka nui i hāʻawi ʻia o ka pahuhopu kaʻawale.

E hoʻohana i kahi ʻike ʻokoʻa ma kēlā me kēia palena waena. ʻO ka nui o ka protein fusion ka mea lawe; ʻAʻole hiki ke hōʻike pololei ʻia ma ke ʻano he target-peptide mass. Loaʻa paha i kahi hakina i hoʻokuʻu ʻia ka hui ʻana ʻole a i ʻole nā ​​ʻano mea pili. E ʻimi i ka nui i ana maoli ʻia, a mālama i ka huina huahana hope loa no nā mea i hōʻike ʻia e kūpono i ka wehewehe molekala i ʻae ʻia. ʻO Glp 1 Grug Pehea e wehewehe pono ai iā Semaglutide?

Pono ka hōʻike e hoʻokaʻawale i kahi hana i manaʻo ʻia mai kahi i hōʻike ʻia. Hoʻokumu ke kiʻi ala ala maikaʻi i kahi hoʻolālā; ʻO nā moʻolelo waena a me nā moʻolelo hope e hoʻokumu i ka mea i loaʻa i ka mea. E ʻike ʻia kēlā ʻokoʻa i ka hoʻohālikelike ʻana i nā manawa a i ʻole ka hoʻoholo ʻana inā pono kahi pae hoʻomohala ʻelua.

Pono kēia palena inā hoʻololi ka pāhana i ka pālākiō. ʻO ke ala e hāʻawi ana i ka pahuhopu hope kūpono i ka pālākiō hoʻokahi e hālāwai paha me kahi bottleneck kaʻawale ʻē aʻe ma hope. E nānā hou i ke kahua i kākoʻo ʻia e nā hōʻike hou ma mua o ka hoʻololi ʻana i ka laina hoʻopau molekala no ka mālama ʻana i kahi koi huahana maikaʻi..

No laila, pono e hoʻokomo i kahi moho recombinant kūpono i kahi hoʻolālā no ka hoʻolālā hope loa a me ka hōʻoia analytical pili. Inā nele kēlā papahana, E mālama i ke ala ma lalo o ka loiloi ma mua o ka haʻi ʻana ua like ia me kahi huahana i hoʻopau ʻia.

Kuhihewa ʻehā: Ke hana nei ka ligation kemika ma kēlā me kēia hui kūpono

ʻO ka manaʻo kuhihewa ʻo ia ka hiki ke ʻoki ʻia i nā ʻāpana ʻelua a hui hou me ka ʻole o ka hoʻololi ʻana i ka kemika.. Pono kahi ala ligation i nā hui hana kūpono a me kahi hoʻolālā kūpono no ka hoʻomākaukau ʻana, lawelawe ʻana, a hui pū i nā ʻāpana.

Ua hoʻokumu ʻo Dawson a me kāna mau hoa hana i ka hopena ma waena o kahi peptide thioester a me kahi ʻāpana me ka cysteine ​​N-terminal., e alakaʻi ana i kahi pilina peptide maoli. Hāʻawi kēlā kemika i kahi hoʻomaka hoʻomaka. ʻAʻole ia e hana i kēlā me kēia hui kūʻokoʻa i kūpono me ka ʻole o ka hoʻolālā hou. Endomorphin

No ka papahana hypothetical, ʻAʻole lawa ka hele ʻana o kahi cysteine ​​ma kahi o ka pahuhopu e koho maʻalahi i ka ligation. Pono ka hui e loiloi i ka palena ʻāpana i manaʻo ʻia, nā palapala māhele i makemake ʻia, hopena hopena, ka hoomaemae ana, a me ke kūlana cysteine ​​hope loa. Hiki i nā hoʻololi hope ke hana i nā koho ʻē aʻe, akā pono kēlā me kēia i kāna hōʻike ponoʻī.

ʻO ka hopena i hoʻoponopono ʻia, hiki i ka ligation ke hoʻoponopono i nā pilikia hui ke kūpono ka hoʻolālā ʻāpana. Hoʻopuka pū ʻo ia i kāna hoʻomākaukau ponoʻī a me nā nīnau analytical. ʻO ka hoʻokaʻawale ʻana i kahi pahu hopu i nā kaulahao pōkole ʻaʻole ia e hōʻoiaʻiʻo i ka hoʻihoʻi hope kiʻekiʻe a i ʻole ka hoʻomaʻemaʻe maʻalahi.

ʻO ka hōʻike kūpono he hoʻolālā hui hilinaʻi i hoʻopili ʻia i ka pahuhopu pololei, ʻaʻole he ʻōlelo maʻamau i loaʻa ka ligation. No ke ala pololei i kākoʻo mua ʻia e nā hōʻike kikoʻī kikoʻī, ʻAʻole hāʻawi ka ʻāpana ʻokoʻa i kahi pono kūpono.

Kuhihewa elima: ʻO kēlā me kēia hoʻohana noiʻi e pono ai ka pūʻolo maikaʻi like

ʻO ka manaʻo kuhi hewa ʻo ia ka hoʻokahi pākēneka maʻemaʻe a i ʻole ka ʻikepili analytical e wehewehe i ka maikaʻi no nā hoʻokolohua peptide āpau.. Hiki i nā hoʻohana like ʻole ke koi i ka ʻike ʻokoʻa, ka nui, haumia, hoʻolālā, a i ʻole ka ʻike olaola. Pono ka hoʻolālā ʻae ʻana e hahai i ka nīnau a nā mea e pane ai.

No ka papahana aʻo, a qualitative analytical comparison and a later quantitative biological study are different decisions. The latter may need stronger target-amount assignment or additional use-specific evidence. A successful first experiment does not automatically supply those missing attributes.

Counterexample to a universal rule: an adequately characterized material may be suitable for a limited qualitative method-development question even when its evidence would be insufficient for absolute quantification. That does not mean crude or poorly defined material is generally acceptable. It means the adequacy of the evidence depends on the stated conclusion.

Pela no, increasing a chromatographic area-purity value does not by itself establish every other attribute. Review the method, identity assignment, wehewehe nui, and relevant limitations separately. ʻAʻole hiki i ka pākēneka kiʻekiʻe i hōʻike ʻia ke uku no ke ʻano molekala hewa.

E kākau i hoʻokahi kikoʻī huahana i hoʻopau ʻia a koi i kēlā me kēia ala moho e helu i kēlā me kēia pae e pono ai e hiki ai. E ʻike i ka hoʻololi i kākoʻo ʻole ʻia a me nā hōʻike e hoʻoholo ai. E koho i kahi ala mai kēlā loiloi pili, me ka huahana precursor a me ka hoʻopuka hope loa i hōʻike ʻia ma ke ʻano he nui like ʻole.

Nīnau pinepine

ʻOi aku ka maikaʻi o ka synthesis solid-phase no kahi peptide pōkole? ʻAʻole. He moho kūpono, akā hoʻololi, kaʻina hana, ka nui i makemakeia, ka hoomaemae ana, a me ka hoʻohana manaʻo e hoʻoholo inā ʻo ia ke ala i kākoʻo maikaʻi ʻia no ka pahuhopu.

Hiki i kahi chromatogram crude ke hoʻokumu i ka hoʻopuka hope loa? Hiki ke kōkua i ka loiloi i kahi waena, akā, ʻo ka ʻae hope e pono ai nā hōʻike kūpono i ka mea a me ka hoʻohana ʻana. Ahahui, hoʻomaʻemaʻe, a ʻo ka hōʻailona hope e pane i nā nīnau like ʻole.

Ke hōʻoiaʻiʻo nei ka hana recombinant i ke ʻano terminal maoli? ʻAʻole. ʻO ke kūkulu, māwae, hana ʻana, a pono e nānā ʻia nā hoʻololi hou ʻana. E hōʻoia i ka pahuhopu kaʻawale ma mua o ka hoʻokaʻawale ʻana i kona ʻano mai ka ʻōlelo wale nō.

I ka manawa hea e noʻonoʻo hou ai ke ala? E nānā hou i ka wā e hōʻike ai nā hōʻike kikoʻī kikoʻī i kahi hui, kaawale, hoʻolālā, ka nui, a i ʻole ka palena maikaʻi, a i ʻole ke hoʻololi ʻia ka pālākiō i manaʻo ʻia. E mālama i ka ʻōlelo kikoʻī hope loa i ka hoʻohālikelike ʻana i nā mea ʻē aʻe.

Bingyan Gao

Bingyan Gao

Mea Hana Pono a me Analytical Kaʻike kumu: ʻO ka hoʻokaʻawale ʻana a me ka ʻike ʻana i nā ʻano haumia, Hoʻomohala ʻano hana HPLC/MS, ka hoʻomaʻemaʻe kiral, a me ka hoʻokō ʻana i nā pharmacopoeias honua.

Pilikino: ʻO Bingyan Gao ka "puka kiaʻi hope" o ka maʻemaʻe peptide a me ka maikaʻi. Maikaʻi ʻo ia i ka hoʻohana ʻana i nā mea analytical kiʻekiʻe kiʻekiʻe a loea i ka hoʻomohala ʻana i nā ʻano hoʻokaʻawale chromatographic maʻamau no nā peptides hoʻololi paʻakikī.. Ua hoʻokumu ʻo ia i kahi ʻōnaehana hoʻomaʻemaʻe pono ʻole e hōʻoia i ka maʻemaʻe o ka huahana 99% a i ʻole kiʻekiʻe aʻe akā ʻike pono a hoʻopau i nā ʻano haumia i hiki ke hoʻoulu i ka immunogenicity. Me ka hoʻomaopopo hohonu ʻana i nā koi hoʻoponopono FDA a me EMA no nā lāʻau peptide, hōʻoia ʻo ia ʻo kēlā me kēia pūʻulu i hoʻokuʻu ʻia mai ka hale hana e hele pū ʻia me kahi palapala hōʻoia o ka ʻike ʻana (COA).

ʻIke ʻia & Nā alakaʻi hoʻoponopono
Nānā ʻia e: Ka poe akamai kumuhana
Kaʻana like i kēia ʻatikala
Home Huli Whatsapp Nā lawelawe Huahana